Professional Medical Education Grants
Novartis funds independent educational programs for US healthcare professionals to advance disease-specific knowledge and clinical practice, with current priorities in Sjögren's Disease and GEP neuroendocrine tumors.
Funder: Novartis
Due Dates: June 29, 2026 (Sjögren's Disease RFP) | July 31, 2026 (GEP Neuroendocrine Tumors RFP) | August 14, 2026 (GEP Neuroendocrine Tumors, if submitted by Office of CME)
Funding Amounts: Sjögren's Disease: Up to $400,000 total (max $300,000 per initiative); GEP NET: Up to $350,000 total; typical award varies by RFP and scope.
Summary: Supports independent medical education programs for US healthcare professionals to advance patient care and disease-focused knowledge across prioritized therapeutic areas.
Key Information: Applications must be submitted via the Novartis Grants Central Station by 5 PM EST on the due date.
Description
Novartis Professional Medical Education Grants fund high-quality, independent educational initiatives designed for US healthcare professionals. The program aims to bridge knowledge gaps, improve clinical practice, and ultimately enhance patient outcomes in both oncology and non-oncology therapeutic areas. Funding is available for a range of activities, including live events, web-based education, enduring materials, and fellowships. Each RFP outlines specific educational needs, learning objectives, and target audiences, with current priority areas including Sjögren's Disease and Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs). Programs must be unbiased, non-promotional, and compliant with all regulatory standards.
